News and reflections from the world of AI

    August 19, 2021

    Aiforia and CompuMed collaborate to enhance organ transplant pathology with AI

    CompuMed and its team of highly experienced physicians provide specialized diagnostic interpretations to their clients who need answers in high urgency situations. Organ Procurement Organizations (OPOs) which provide organs and tissue for transplant centers need critical information relating to for example pathology, cardiology, or radiology to improve donor management, decrease donor evaluation ...
    Written by Aiforia
    June 21, 2021

    Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

    Portsmouth, NH, USA, June 21, 2021 – Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for Aiforia’s comprehensive portfolio of workflow enhancing solutions which enable ...
    Written by Aiforia
    June 10, 2021

    Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

    First-of-its kind diagnostic tool Aiforia today announced the CE-IVD Mark for the Aiforia® Clinical AI Model for Breast Cancer; Ki67, a widely used key biomarker in breast cancer diagnostics across pathology labs around the world. The AI Model is able to calculate Ki67 positive and negative cells in invasive areas of human breast tissue in whole slide images (WSI) as well as in specific areas — ...
    Written by Aiforia
    June 3, 2021

    Aiforia Raises €12.6M in Series B Funding to Enhance Precision Diagnostics and Preclinical Analysis in Pathology

    Helsinki – June 3, 2021 - Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology, announced today the closing of the first €12.6M tranche of their Series B round. The funding round has the potential to reach €25.2M if investors exercise the optional second tranche. The funding round is led by Epredia's UK entity, a subsidiary of PHC ...
    Written by Aiforia
    April 8, 2021

    New Finnish consortium aims to enhance diagnostics and combat pandemics

    The COVID-19 pandemic has highlighted the importance of efficient diagnostic methods. Beyond battling pandemics, there are also significant diagnostic needs in everyday healthcare but healthcare systems around the world are struggling with rapidly increasing costs. The Future of Diagnostics (FUDIS) co-innovation consortium was created to address these challenges — to develop reliable, rapid, ...
    Written by Aiforia
    March 15, 2021

    Aiforia appoints Swedbank as lead advisor to explore financing options

    Aiforia Technologies Oy ("Aiforia" or "the Company") has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Nasdaq Helsinki First North.
    Written by Aiforia
    1 2 3 4 5